Molecular Diagnostics Market
Molecular Diagnostics Market - Global Industry Assessment & Forecast
Segments Covered
- By Product & Service Reagents & Kits, Instruments, Services & Software
- By Test Type Lab Tests, PoC Tests
- By Sample Type Blood, Serum, & Plasma, Urine, Other Sample Types
- By Technology Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next-generation Sequencing, In Situ Hybridization, DNA Microarrays, Other Technologies
- By Application Infectious Disease Diagnostics, Oncology Testing, Genetic Testing, COVID-19, Other Applications
- By End User Diagnostic Laboratories, Hospitals & Clinics, Other End Users
- By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base Year: | 2022 |
Forecast Years: | 2023 - 2030 |
Historical Years: | 2017 - 2021 |
Revenue 2022: | USD 14.9 Billion |
Revenue 2030: | USD 35.8 Billion |
Revenue CAGR (2023 - 2030): | 11.6% |
Fastest Growing Region (2023 - 2030) | Asia Pacific |
Largest Region (2022): | North America |
Customization Offered
- Cross-segment Market Size and Analysis for Mentioned Segments
- Additional Company Profiles (Upto 5 With No Cost)
- Additional Countries (Apart From Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request Customization Speak To Analyst
-
Executive Dashboard
- Strategic Imperatives
-
Premium Insights
- Top 3 Trends to Watch
- Demand and Supply Trends
- Top 3 Strategies Followed by Major Players
- Top 3 Predictions by Vantage Market Research
- Top Investment Pockets
- Insights from Primary Respondents
-
Global Molecular Diagnostics Market - Segment Analysis
- Overview
- Global Molecular Diagnostics Market, 2016 - 2028 (USD Million)
-
Global Molecular Diagnostics Market - by Product & Service
- By Reagents & Kits
- By Instruments
- By Services & Software
-
Global Molecular Diagnostics Market - by Test Type
- By Lab Tests
- By PoC Tests
-
Global Molecular Diagnostics Market - by Sample Type
- By Blood, Serum, & Plasma
- By Urine
- By Other Sample Types
-
Global Molecular Diagnostics Market - by Technology
- By Polymerase Chain Reaction
- By Isothermal Nucleic Acid Amplification Technology
- By DNA Sequencing & Next-generation Sequencing
- By In Situ Hybridization
- By DNA Microarrays
- By Other Technologies
-
Global Molecular Diagnostics Market - by Application
- By Infectious Disease Diagnostics
- By Oncology Testing
- By Genetic Testing
- By COVID-19
- By Other Applications
-
Global Molecular Diagnostics Market - by End User
- By Diagnostic Laboratories
- By Hospitals & Clinics
- By Other End Users
-
Global Molecular Diagnostics Market - by region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
- Market comparative analysis
-
North America Molecular Diagnostics Market - Segment Analysis
- Overview
- North America Molecular Diagnostics Market, 2016 - 2028 (USD Million)
-
North America Molecular Diagnostics Market, by Product & Service
- By Reagents & Kits
- By Instruments
- By Services & Software
-
North America Molecular Diagnostics Market, by Test Type
- By Lab Tests
- By PoC Tests
-
North America Molecular Diagnostics Market, by Sample Type
- By Blood, Serum, & Plasma
- By Urine
- By Other Sample Types
-
North America Molecular Diagnostics Market, by Technology
- By Polymerase Chain Reaction
- By Isothermal Nucleic Acid Amplification Technology
- By DNA Sequencing & Next-generation Sequencing
- By In Situ Hybridization
- By DNA Microarrays
- By Other Technologies
-
North America Molecular Diagnostics Market, by Application
- By Infectious Disease Diagnostics
- By Oncology Testing
- By Genetic Testing
- By COVID-19
- By Other Applications
-
North America Molecular Diagnostics Market, by End User
- By Diagnostic Laboratories
- By Hospitals & Clinics
- By Other End Users
-
North America Molecular Diagnostics Market, by Country
- U.S.
- U.S. Molecular Diagnostics Market, By Product & Service
- By Reagents & Kits
- By Instruments
- By Services & Software
- U.S. Molecular Diagnostics Market, By Test Type
- By Lab Tests
- By PoC Tests
- U.S. Molecular Diagnostics Market, By Sample Type
- By Blood, Serum, & Plasma
- By Urine
- By Other Sample Types
- U.S. Molecular Diagnostics Market, By Technology
- By Polymerase Chain Reaction
- By Isothermal Nucleic Acid Amplification Technology
- By DNA Sequencing & Next-generation Sequencing
- By In Situ Hybridization
- By DNA Microarrays
- By Other Technologies
- U.S. Molecular Diagnostics Market, By Application
- By Infectious Disease Diagnostics
- By Oncology Testing
- By Genetic Testing
- By COVID-19
- By Other Applications
- U.S. Molecular Diagnostics Market, By End User
- By Diagnostic Laboratories
- By Hospitals & Clinics
- By Other End Users
- U.S. Molecular Diagnostics Market, By Product & Service
- Canada
- Canada Molecular Diagnostics Market, By Product & Service
- By Reagents & Kits
- By Instruments
- By Services & Software
- Canada Molecular Diagnostics Market, By Test Type
- By Lab Tests
- By PoC Tests
- Canada Molecular Diagnostics Market, By Sample Type
- By Blood, Serum, & Plasma
- By Urine
- By Other Sample Types
- Canada Molecular Diagnostics Market, By Technology
- By Polymerase Chain Reaction
- By Isothermal Nucleic Acid Amplification Technology
- By DNA Sequencing & Next-generation Sequencing
- By In Situ Hybridization
- By DNA Microarrays
- By Other Technologies
- Canada Molecular Diagnostics Market, By Application
- By Infectious Disease Diagnostics
- By Oncology Testing
- By Genetic Testing
- By COVID-19
- By Other Applications
- Canada Molecular Diagnostics Market, By End User
- By Diagnostic Laboratories
- By Hospitals & Clinics
- By Other End Users
- Canada Molecular Diagnostics Market, By Product & Service
- Mexico
- Mexico Molecular Diagnostics Market, By Product & Service
- By Reagents & Kits
- By Instruments
- By Services & Software
- Mexico Molecular Diagnostics Market, By Test Type
- By Lab Tests
- By PoC Tests
- Mexico Molecular Diagnostics Market, By Sample Type
- By Blood, Serum, & Plasma
- By Urine
- By Other Sample Types
- Mexico Molecular Diagnostics Market, By Technology
- By Polymerase Chain Reaction
- By Isothermal Nucleic Acid Amplification Technology
- By DNA Sequencing & Next-generation Sequencing
- By In Situ Hybridization
- By DNA Microarrays
- By Other Technologies
- Mexico Molecular Diagnostics Market, By Application
- By Infectious Disease Diagnostics
- By Oncology Testing
- By Genetic Testing
- By COVID-19
- By Other Applications
- Mexico Molecular Diagnostics Market, By End User
- By Diagnostic Laboratories
- By Hospitals & Clinics
- By Other End Users
- Mexico Molecular Diagnostics Market, By Product & Service
- U.S.
-
Europe Molecular Diagnostics Market - Segment Analysis
- Overview
- Europe Molecular Diagnostics Market, 2016 - 2028 (USD Million)
-
Europe Molecular Diagnostics Market, by Product & Service
- By Reagents & Kits
- By Instruments
- By Services & Software
-
Europe Molecular Diagnostics Market, by Test Type
- By Lab Tests
- By PoC Tests
-
Europe Molecular Diagnostics Market, by Sample Type
- By Blood, Serum, & Plasma
- By Urine
- By Other Sample Types
-
Europe Molecular Diagnostics Market, by Technology
- By Polymerase Chain Reaction
- By Isothermal Nucleic Acid Amplification Technology
- By DNA Sequencing & Next-generation Sequencing
- By In Situ Hybridization
- By DNA Microarrays
- By Other Technologies
-
Europe Molecular Diagnostics Market, by Application
- By Infectious Disease Diagnostics
- By Oncology Testing
- By Genetic Testing
- By COVID-19
- By Other Applications
-
Europe Molecular Diagnostics Market, by End User
- By Diagnostic Laboratories
- By Hospitals & Clinics
- By Other End Users
-
Europe Molecular Diagnostics Market, by Country
- Germany
- Germany Molecular Diagnostics Market, By Product & Service
- By Reagents & Kits
- By Instruments
- By Services & Software
- Germany Molecular Diagnostics Market, By Test Type
- By Lab Tests
- By PoC Tests
- Germany Molecular Diagnostics Market, By Sample Type
- By Blood, Serum, & Plasma
- By Urine
- By Other Sample Types
- Germany Molecular Diagnostics Market, By Technology
- By Polymerase Chain Reaction
- By Isothermal Nucleic Acid Amplification Technology
- By DNA Sequencing & Next-generation Sequencing
- By In Situ Hybridization
- By DNA Microarrays
- By Other Technologies
- Germany Molecular Diagnostics Market, By Application
- By Infectious Disease Diagnostics
- By Oncology Testing
- By Genetic Testing
- By COVID-19
- By Other Applications
- Germany Molecular Diagnostics Market, By End User
- By Diagnostic Laboratories
- By Hospitals & Clinics
- By Other End Users
- Germany Molecular Diagnostics Market, By Product & Service
- UK
- UK Market, By Product & Service
- By Reagents & Kits
- By Instruments
- By Services & Software
- UK Market, By Test Type
- By Lab Tests
- By PoC Tests
- UK Market, By Sample Type
- By Blood, Serum, & Plasma
- By Urine
- By Other Sample Types
- UK Market, By Technology
- By Polymerase Chain Reaction
- By Isothermal Nucleic Acid Amplification Technology
- By DNA Sequencing & Next-generation Sequencing
- By In Situ Hybridization
- By DNA Microarrays
- By Other Technologies
- UK Market, By Application
- By Infectious Disease Diagnostics
- By Oncology Testing
- By Genetic Testing
- By COVID-19
- By Other Applications
- UK Market, By End User
- By Diagnostic Laboratories
- By Hospitals & Clinics
- By Other End Users
- UK Market, By Product & Service
- France
- France Molecular Diagnostics Market, By Product & Service
- By Reagents & Kits
- By Instruments
- By Services & Software
- France Molecular Diagnostics Market, By Test Type
- By Lab Tests
- By PoC Tests
- France Molecular Diagnostics Market, By Sample Type
- By Blood, Serum, & Plasma
- By Urine
- By Other Sample Types
- France Molecular Diagnostics Market, By Technology
- By Polymerase Chain Reaction
- By Isothermal Nucleic Acid Amplification Technology
- By DNA Sequencing & Next-generation Sequencing
- By In Situ Hybridization
- By DNA Microarrays
- By Other Technologies
- France Molecular Diagnostics Market, By Application
- By Infectious Disease Diagnostics
- By Oncology Testing
- By Genetic Testing
- By COVID-19
- By Other Applications
- France Molecular Diagnostics Market, By End User
- By Diagnostic Laboratories
- By Hospitals & Clinics
- By Other End Users
- France Molecular Diagnostics Market, By Product & Service
- Spain
- Spain Molecular Diagnostics Market, By Product & Service
- By Reagents & Kits
- By Instruments
- By Services & Software
- Spain Molecular Diagnostics Market, By Test Type
- By Lab Tests
- By PoC Tests
- Spain Molecular Diagnostics Market, By Sample Type
- By Blood, Serum, & Plasma
- By Urine
- By Other Sample Types
- Spain Molecular Diagnostics Market, By Technology
- By Polymerase Chain Reaction
- By Isothermal Nucleic Acid Amplification Technology
- By DNA Sequencing & Next-generation Sequencing
- By In Situ Hybridization
- By DNA Microarrays
- By Other Technologies
- Spain Molecular Diagnostics Market, By Application
- By Infectious Disease Diagnostics
- By Oncology Testing
- By Genetic Testing
- By COVID-19
- By Other Applications
- Spain Molecular Diagnostics Market, By End User
- By Diagnostic Laboratories
- By Hospitals & Clinics
- By Other End Users
- Spain Molecular Diagnostics Market, By Product & Service
- Italy
- Italy Molecular Diagnostics Market, By Product & Service
- By Reagents & Kits
- By Instruments
- By Services & Software
- Italy Molecular Diagnostics Market, By Test Type
- By Lab Tests
- By PoC Tests
- Italy Molecular Diagnostics Market, By Sample Type
- By Blood, Serum, & Plasma
- By Urine
- By Other Sample Types
- Italy Molecular Diagnostics Market, By Technology
- By Polymerase Chain Reaction
- By Isothermal Nucleic Acid Amplification Technology
- By DNA Sequencing & Next-generation Sequencing
- By In Situ Hybridization
- By DNA Microarrays
- By Other Technologies
- Italy Molecular Diagnostics Market, By Application
- By Infectious Disease Diagnostics
- By Oncology Testing
- By Genetic Testing
- By COVID-19
- By Other Applications
- Italy Molecular Diagnostics Market, By End User
- By Diagnostic Laboratories
- By Hospitals & Clinics
- By Other End Users
- Italy Molecular Diagnostics Market, By Product & Service
- BENELUX
- BENELUX Molecular Diagnostics Market, By Product & Service
- By Reagents & Kits
- By Instruments
- By Services & Software
- BENELUX Molecular Diagnostics Market, By Test Type
- By Lab Tests
- By PoC Tests
- BENELUX Molecular Diagnostics Market, By Sample Type
- By Blood, Serum, & Plasma
- By Urine
- By Other Sample Types
- BENELUX Molecular Diagnostics Market, By Technology
- By Polymerase Chain Reaction
- By Isothermal Nucleic Acid Amplification Technology
- By DNA Sequencing & Next-generation Sequencing
- By In Situ Hybridization
- By DNA Microarrays
- By Other Technologies
- BENELUX Molecular Diagnostics Market, By Application
- By Infectious Disease Diagnostics
- By Oncology Testing
- By Genetic Testing
- By COVID-19
- By Other Applications
- BENELUX Molecular Diagnostics Market, By End User
- By Diagnostic Laboratories
- By Hospitals & Clinics
- By Other End Users
- BENELUX Molecular Diagnostics Market, By Product & Service
- Rest of Europe
- Rest Of Europe Molecular Diagnostics Market, By Product & Service
- By Reagents & Kits
- By Instruments
- By Services & Software
- Rest Of Europe Molecular Diagnostics Market, By Test Type
- By Lab Tests
- By PoC Tests
- Rest Of Europe Molecular Diagnostics Market, By Sample Type
- By Blood, Serum, & Plasma
- By Urine
- By Other Sample Types
- Rest Of Europe Molecular Diagnostics Market, By Technology
- By Polymerase Chain Reaction
- By Isothermal Nucleic Acid Amplification Technology
- By DNA Sequencing & Next-generation Sequencing
- By In Situ Hybridization
- By DNA Microarrays
- By Other Technologies
- Rest Of Europe Molecular Diagnostics Market, By Application
- By Infectious Disease Diagnostics
- By Oncology Testing
- By Genetic Testing
- By COVID-19
- By Other Applications
- Rest Of Europe Molecular Diagnostics Market, By End User
- By Diagnostic Laboratories
- By Hospitals & Clinics
- By Other End Users
- Rest Of Europe Molecular Diagnostics Market, By Product & Service
- Germany
-
Asia Pacific Molecular Diagnostics Market - Segment Analysis
- Overview
- Asia Pacific Molecular Diagnostics Market, 2016 - 2028 (USD Million)
-
Asia Pacific Molecular Diagnostics Market, by Product & Service
- By Reagents & Kits
- By Instruments
- By Services & Software
-
Asia Pacific Molecular Diagnostics Market, by Test Type
- By Lab Tests
- By PoC Tests
-
Asia Pacific Molecular Diagnostics Market, by Sample Type
- By Blood, Serum, & Plasma
- By Urine
- By Other Sample Types
-
Asia Pacific Molecular Diagnostics Market, by Technology
- By Polymerase Chain Reaction
- By Isothermal Nucleic Acid Amplification Technology
- By DNA Sequencing & Next-generation Sequencing
- By In Situ Hybridization
- By DNA Microarrays
- By Other Technologies
-
Asia Pacific Molecular Diagnostics Market, by Application
- By Infectious Disease Diagnostics
- By Oncology Testing
- By Genetic Testing
- By COVID-19
- By Other Applications
-
Asia Pacific Molecular Diagnostics Market, by End User
- By Diagnostic Laboratories
- By Hospitals & Clinics
- By Other End Users
-
Asia Pacific Molecular Diagnostics Market, by Country
- China
- China Molecular Diagnostics Market, By Product & Service
- By Reagents & Kits
- By Instruments
- By Services & Software
- China Molecular Diagnostics Market, By Test Type
- By Lab Tests
- By PoC Tests
- China Molecular Diagnostics Market, By Sample Type
- By Blood, Serum, & Plasma
- By Urine
- By Other Sample Types
- China Molecular Diagnostics Market, By Technology
- By Polymerase Chain Reaction
- By Isothermal Nucleic Acid Amplification Technology
- By DNA Sequencing & Next-generation Sequencing
- By In Situ Hybridization
- By DNA Microarrays
- By Other Technologies
- China Molecular Diagnostics Market, By Application
- By Infectious Disease Diagnostics
- By Oncology Testing
- By Genetic Testing
- By COVID-19
- By Other Applications
- China Molecular Diagnostics Market, By End User
- By Diagnostic Laboratories
- By Hospitals & Clinics
- By Other End Users
- China Molecular Diagnostics Market, By Product & Service
- Japan
- Japan Molecular Diagnostics Market, By Product & Service
- By Reagents & Kits
- By Instruments
- By Services & Software
- Japan Molecular Diagnostics Market, By Test Type
- By Lab Tests
- By PoC Tests
- Japan Molecular Diagnostics Market, By Sample Type
- By Blood, Serum, & Plasma
- By Urine
- By Other Sample Types
- Japan Molecular Diagnostics Market, By Technology
- By Polymerase Chain Reaction
- By Isothermal Nucleic Acid Amplification Technology
- By DNA Sequencing & Next-generation Sequencing
- By In Situ Hybridization
- By DNA Microarrays
- By Other Technologies
- Japan Molecular Diagnostics Market, By Application
- By Infectious Disease Diagnostics
- By Oncology Testing
- By Genetic Testing
- By COVID-19
- By Other Applications
- Japan Molecular Diagnostics Market, By End User
- By Diagnostic Laboratories
- By Hospitals & Clinics
- By Other End Users
- Japan Molecular Diagnostics Market, By Product & Service
- India
- India Molecular Diagnostics Market, By Product & Service
- By Reagents & Kits
- By Instruments
- By Services & Software
- India Molecular Diagnostics Market, By Test Type
- By Lab Tests
- By PoC Tests
- India Molecular Diagnostics Market, By Sample Type
- By Blood, Serum, & Plasma
- By Urine
- By Other Sample Types
- India Molecular Diagnostics Market, By Technology
- By Polymerase Chain Reaction
- By Isothermal Nucleic Acid Amplification Technology
- By DNA Sequencing & Next-generation Sequencing
- By In Situ Hybridization
- By DNA Microarrays
- By Other Technologies
- India Molecular Diagnostics Market, By Application
- By Infectious Disease Diagnostics
- By Oncology Testing
- By Genetic Testing
- By COVID-19
- By Other Applications
- India Molecular Diagnostics Market, By End User
- By Diagnostic Laboratories
- By Hospitals & Clinics
- By Other End Users
- India Molecular Diagnostics Market, By Product & Service
- South Korea
- South Korea Molecular Diagnostics Market, By Product & Service
- By Reagents & Kits
- By Instruments
- By Services & Software
- South Korea Molecular Diagnostics Market, By Test Type
- By Lab Tests
- By PoC Tests
- South Korea Molecular Diagnostics Market, By Sample Type
- By Blood, Serum, & Plasma
- By Urine
- By Other Sample Types
- South Korea Molecular Diagnostics Market, By Technology
- By Polymerase Chain Reaction
- By Isothermal Nucleic Acid Amplification Technology
- By DNA Sequencing & Next-generation Sequencing
- By In Situ Hybridization
- By DNA Microarrays
- By Other Technologies
- South Korea Molecular Diagnostics Market, By Application
- By Infectious Disease Diagnostics
- By Oncology Testing
- By Genetic Testing
- By COVID-19
- By Other Applications
- South Korea Molecular Diagnostics Market, By End User
- By Diagnostic Laboratories
- By Hospitals & Clinics
- By Other End Users
- South Korea Molecular Diagnostics Market, By Product & Service
- South East Asia
- South East Asia Molecular Diagnostics Market, By Product & Service
- By Reagents & Kits
- By Instruments
- By Services & Software
- South East Asia Molecular Diagnostics Market, By Test Type
- By Lab Tests
- By PoC Tests
- South East Asia Molecular Diagnostics Market, By Sample Type
- By Blood, Serum, & Plasma
- By Urine
- By Other Sample Types
- South East Asia Molecular Diagnostics Market, By Technology
- By Polymerase Chain Reaction
- By Isothermal Nucleic Acid Amplification Technology
- By DNA Sequencing & Next-generation Sequencing
- By In Situ Hybridization
- By DNA Microarrays
- By Other Technologies
- South East Asia Molecular Diagnostics Market, By Application
- By Infectious Disease Diagnostics
- By Oncology Testing
- By Genetic Testing
- By COVID-19
- By Other Applications
- South East Asia Molecular Diagnostics Market, By End User
- By Diagnostic Laboratories
- By Hospitals & Clinics
- By Other End Users
- South East Asia Molecular Diagnostics Market, By Product & Service
- Rest of Asia Pacific
- Rest of Asia Pacific Molecular Diagnostics Market, By Product & Service
- By Reagents & Kits
- By Instruments
- By Services & Software
- Rest of Asia Pacific Molecular Diagnostics Market, By Test Type
- By Lab Tests
- By PoC Tests
- Rest of Asia Pacific Molecular Diagnostics Market, By Sample Type
- By Blood, Serum, & Plasma
- By Urine
- By Other Sample Types
- Rest of Asia Pacific Molecular Diagnostics Market, By Technology
- By Polymerase Chain Reaction
- By Isothermal Nucleic Acid Amplification Technology
- By DNA Sequencing & Next-generation Sequencing
- By In Situ Hybridization
- By DNA Microarrays
- By Other Technologies
- Rest of Asia Pacific Molecular Diagnostics Market, By Application
- By Infectious Disease Diagnostics
- By Oncology Testing
- By Genetic Testing
- By COVID-19
- By Other Applications
- Rest of Asia Pacific Molecular Diagnostics Market, By End User
- By Diagnostic Laboratories
- By Hospitals & Clinics
- By Other End Users
- Rest of Asia Pacific Molecular Diagnostics Market, By Product & Service
- China
-
Latin America Molecular Diagnostics Market - Segment Analysis
- Overview
- Latin America Molecular Diagnostics Market, 2016 - 2028 (USD Million)
-
Latin America Molecular Diagnostics Market, by Product & Service
- By Reagents & Kits
- By Instruments
- By Services & Software
-
Latin America Molecular Diagnostics Market, by Test Type
- By Lab Tests
- By PoC Tests
-
Latin America Molecular Diagnostics Market, by Sample Type
- By Blood, Serum, & Plasma
- By Urine
- By Other Sample Types
-
Latin America Molecular Diagnostics Market, by Technology
- By Polymerase Chain Reaction
- By Isothermal Nucleic Acid Amplification Technology
- By DNA Sequencing & Next-generation Sequencing
- By In Situ Hybridization
- By DNA Microarrays
- By Other Technologies
-
Latin America Molecular Diagnostics Market, by Application
- By Infectious Disease Diagnostics
- By Oncology Testing
- By Genetic Testing
- By COVID-19
- By Other Applications
-
Latin America Molecular Diagnostics Market, by End User
- By Diagnostic Laboratories
- By Hospitals & Clinics
- By Other End Users
-
Latin America Molecular Diagnostics Market, by Country
- Brazil
- Brazil Molecular Diagnostics Market, By Product & Service
- By Reagents & Kits
- By Instruments
- By Services & Software
- Brazil Molecular Diagnostics Market, By Test Type
- By Lab Tests
- By PoC Tests
- Brazil Molecular Diagnostics Market, By Sample Type
- By Blood, Serum, & Plasma
- By Urine
- By Other Sample Types
- Brazil Molecular Diagnostics Market, By Technology
- By Polymerase Chain Reaction
- By Isothermal Nucleic Acid Amplification Technology
- By DNA Sequencing & Next-generation Sequencing
- By In Situ Hybridization
- By DNA Microarrays
- By Other Technologies
- Brazil Molecular Diagnostics Market, By Application
- By Infectious Disease Diagnostics
- By Oncology Testing
- By Genetic Testing
- By COVID-19
- By Other Applications
- Brazil Molecular Diagnostics Market, By End User
- By Diagnostic Laboratories
- By Hospitals & Clinics
- By Other End Users
- Brazil Molecular Diagnostics Market, By Product & Service
- Argentina
- Argentina Molecular Diagnostics Market, By Product & Service
- By Reagents & Kits
- By Instruments
- By Services & Software
- Argentina Molecular Diagnostics Market, By Test Type
- By Lab Tests
- By PoC Tests
- Argentina Molecular Diagnostics Market, By Sample Type
- By Blood, Serum, & Plasma
- By Urine
- By Other Sample Types
- Argentina Molecular Diagnostics Market, By Technology
- By Polymerase Chain Reaction
- By Isothermal Nucleic Acid Amplification Technology
- By DNA Sequencing & Next-generation Sequencing
- By In Situ Hybridization
- By DNA Microarrays
- By Other Technologies
- Argentina Molecular Diagnostics Market, By Application
- By Infectious Disease Diagnostics
- By Oncology Testing
- By Genetic Testing
- By COVID-19
- By Other Applications
- Argentina Molecular Diagnostics Market, By End User
- By Diagnostic Laboratories
- By Hospitals & Clinics
- By Other End Users
- Argentina Molecular Diagnostics Market, By Product & Service
- Rest of Latin America
- Rest of Latin America Molecular Diagnostics Market, By Product & Service
- By Reagents & Kits
- By Instruments
- By Services & Software
- Rest of Latin America Molecular Diagnostics Market, By Test Type
- By Lab Tests
- By PoC Tests
- Rest of Latin America Molecular Diagnostics Market, By Sample Type
- By Blood, Serum, & Plasma
- By Urine
- By Other Sample Types
- Rest of Latin America Molecular Diagnostics Market, By Technology
- By Polymerase Chain Reaction
- By Isothermal Nucleic Acid Amplification Technology
- By DNA Sequencing & Next-generation Sequencing
- By In Situ Hybridization
- By DNA Microarrays
- By Other Technologies
- Rest of Latin America Molecular Diagnostics Market, By Application
- By Infectious Disease Diagnostics
- By Oncology Testing
- By Genetic Testing
- By COVID-19
- By Other Applications
- Rest of Latin America Molecular Diagnostics Market, By End User
- By Diagnostic Laboratories
- By Hospitals & Clinics
- By Other End Users
- Rest of Latin America Molecular Diagnostics Market, By Product & Service
- Brazil
-
Middle East & Africa Molecular Diagnostics Market - Segment Analysis
- Overview
- Middle East & Africa Molecular Diagnostics Market, 2016 - 2028 (USD Million)
-
Middle East & Africa Molecular Diagnostics Market, by Product & Service
- By Reagents & Kits
- By Instruments
- By Services & Software
-
Middle East & Africa Molecular Diagnostics Market, by Test Type
- By Lab Tests
- By PoC Tests
-
Middle East & Africa Molecular Diagnostics Market, by Sample Type
- By Blood, Serum, & Plasma
- By Urine
- By Other Sample Types
-
Middle East & Africa Molecular Diagnostics Market, by Technology
- By Polymerase Chain Reaction
- By Isothermal Nucleic Acid Amplification Technology
- By DNA Sequencing & Next-generation Sequencing
- By In Situ Hybridization
- By DNA Microarrays
- By Other Technologies
-
Middle East & Africa Molecular Diagnostics Market, by Application
- By Infectious Disease Diagnostics
- By Oncology Testing
- By Genetic Testing
- By COVID-19
- By Other Applications
-
Middle East & Africa Molecular Diagnostics Market, by End User
- By Diagnostic Laboratories
- By Hospitals & Clinics
- By Other End Users
-
Middle East & Africa Molecular Diagnostics Market, by Country
- GCC Countries
- GCC Countries Molecular Diagnostics Market, By Product & Service
- By Reagents & Kits
- By Instruments
- By Services & Software
- GCC Countries Molecular Diagnostics Market, By Test Type
- By Lab Tests
- By PoC Tests
- GCC Countries Molecular Diagnostics Market, By Sample Type
- By Blood, Serum, & Plasma
- By Urine
- By Other Sample Types
- GCC Countries Molecular Diagnostics Market, By Technology
- By Polymerase Chain Reaction
- By Isothermal Nucleic Acid Amplification Technology
- By DNA Sequencing & Next-generation Sequencing
- By In Situ Hybridization
- By DNA Microarrays
- By Other Technologies
- GCC Countries Molecular Diagnostics Market, By Application
- By Infectious Disease Diagnostics
- By Oncology Testing
- By Genetic Testing
- By COVID-19
- By Other Applications
- GCC Countries Molecular Diagnostics Market, By End User
- By Diagnostic Laboratories
- By Hospitals & Clinics
- By Other End Users
- GCC Countries Molecular Diagnostics Market, By Product & Service
- South Africa
- South Africa Molecular Diagnostics Market, By Product & Service
- By Reagents & Kits
- By Instruments
- By Services & Software
- South Africa Molecular Diagnostics Market, By Test Type
- By Lab Tests
- By PoC Tests
- South Africa Molecular Diagnostics Market, By Sample Type
- By Blood, Serum, & Plasma
- By Urine
- By Other Sample Types
- South Africa Molecular Diagnostics Market, By Technology
- By Polymerase Chain Reaction
- By Isothermal Nucleic Acid Amplification Technology
- By DNA Sequencing & Next-generation Sequencing
- By In Situ Hybridization
- By DNA Microarrays
- By Other Technologies
- South Africa Molecular Diagnostics Market, By Application
- By Infectious Disease Diagnostics
- By Oncology Testing
- By Genetic Testing
- By COVID-19
- By Other Applications
- South Africa Molecular Diagnostics Market, By End User
- By Diagnostic Laboratories
- By Hospitals & Clinics
- By Other End Users
- South Africa Molecular Diagnostics Market, By Product & Service
- Rest of Middle East & Africa
- Rest of Middle East & Africa Molecular Diagnostics Market, By Product & Service
- By Reagents & Kits
- By Instruments
- By Services & Software
- Rest of Middle East & Africa Molecular Diagnostics Market, By Test Type
- By Lab Tests
- By PoC Tests
- Rest of Middle East & Africa Molecular Diagnostics Market, By Sample Type
- By Blood, Serum, & Plasma
- By Urine
- By Other Sample Types
- Rest of Middle East & Africa Molecular Diagnostics Market, By Technology
- By Polymerase Chain Reaction
- By Isothermal Nucleic Acid Amplification Technology
- By DNA Sequencing & Next-generation Sequencing
- By In Situ Hybridization
- By DNA Microarrays
- By Other Technologies
- Rest of Middle East & Africa Molecular Diagnostics Market, By Application
- By Infectious Disease Diagnostics
- By Oncology Testing
- By Genetic Testing
- By COVID-19
- By Other Applications
- Rest of Middle East & Africa Molecular Diagnostics Market, By End User
- By Diagnostic Laboratories
- By Hospitals & Clinics
- By Other End Users
- Rest of Middle East & Africa Molecular Diagnostics Market, By Product & Service
- GCC Countries
-
Key Market Dynamics
- Introduction
- Market Drivers
- Market Restraints
- Market Opportunities
- Porter's Five Forces Analysis
- PEST Analysis
- Regulatory Landscape
- Technology Landscape
- Regional Market Trends
-
COVID 19 Impact Analysis
- Key strategies undertaken by companies to tackle COVID-19
- Short term dynamics
- Long term dynamics
-
Marketing Stratagy Analysis
- Marketing Channel
- Direct Marketing
- Indirect Marketing
- Marketing Channel Development Trends
-
Competative Landscape
- Competition Matrix - 2021
- Company Market Share Analysis - 2021
- Key Company Activities, 2018 - 2021
- Strategic Developments - Heat Map Analysis
- Company Offering Evaluation
- Company Regional Presence Evaluation
-
Company Profiles
- Becton Dickinson and Company (U.S.)
- bioMérieux SA (France)
- Bio-Rad Laboratories Inc. (U.S.)
- Abbott Laboratories (U.S.)
- Agilent Technologies Inc. (U.S.)
- Danaher Corp. (U.S.)
- Hologic Inc. (U.S.)
- Illumina Inc. (U.S.)
- Johnson & Johnson Services Inc. (U.S.)
- Grifols S.A. (Spain)
- QIAGEN (Germany)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Siemens Healthineers AG (Germany)
- Sysmex Corporation (Japan)
- Key Primary Respondents - VERBATIM
- Discussion Guide
- Customization Offered
- Annexure
- List of Figures
- List of Tables
- List of Abbreviations
FAQ
Frequently Asked Question
What is the global demand for Molecular Diagnostics in terms of revenue?
-
The global Molecular Diagnostics valued at USD 14.9 Billion in 2022 and is expected to reach USD 35.8 Billion in 2030 growing at a CAGR of 11.6%.
Which are the prominent players in the market?
-
The prominent players in the market are Becton Dickinson and Company (U.S.), bioMérieux SA (France), Bio-Rad Laboratories Inc. (U.S.), Abbott Laboratories (U.S.), Agilent Technologies Inc. (U.S.), Danaher Corp. (U.S.), Hologic Inc. (U.S.), Illumina Inc. (U.S.), Johnson & Johnson Services Inc. (U.S.), Grifols S.A. (Spain), QIAGEN (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Siemens Healthineers AG (Germany), Sysmex Corporation (Japan).
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 11.6% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Molecular Diagnostics include
- Introduction of technologically advanced products
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Molecular Diagnostics in 2022.